Skip to main content
INTEGRA LIFESCIENCES HOLDINGS CORP logo

INTEGRA LIFESCIENCES HOLDINGS CORP — Investor Relations & Filings

Ticker · IART ISIN · US4579852082 LEI · WB7IJCYY8YFTENS4O147 US Manufacturing
Filings indexed 1,328 across all filing types
Latest filing 2026-05-05 Interim / Quarterly Rep…
Country US United States of America
Listing US IART

About INTEGRA LIFESCIENCES HOLDINGS CORP

https://www.integralife.com/

Integra LifeSciences Holdings Corp. is a global medical technology company specializing in neurosurgery and regenerative tissue technologies. The company is a leader in neurosurgery, offering a broad portfolio of products for dural access and repair, cerebral spinal fluid management, and the treatment of neurological conditions. In regenerative medicine, Integra develops and manufactures solutions for skin regeneration, nerve and tendon repair, and complex wound care, often utilizing engineered collagen-based products. The company also provides a range of surgical instruments for use in reconstructive and general surgery.

Recent filings

Filing Released Lang Actions
10-Q - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-05 English
8-K - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)
Regulatory Filings
2026-05-05 English
8-K - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)
Regulatory Filings
2026-05-05 English
8-K - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)
Regulatory Filings
2026-04-15 English
SCHEDULE 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)
Major Shareholding Notification
2026-03-27 English
S-3ASR - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)
Regulatory Filings
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.